canakinumab

CHEBI:CHEBI_749992

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

generic_name
CANAKINUMAB
rxcui
1864326
product_type
BULK INGREDIENT
listing_expiration_date
20251231
dosage_form
LIQUID
route
SUBCUTANEOUS
marketing_category
BULK INGREDIENT
active_ingredient_strength
1 kg/kg
labeler_name
NOVARTIS PHARMA SAS
manufacturer_name
Novartis Pharmaceuticals Corporation
marketing_start_date
20161222
package_marketing_start_date
01-JUL-24
active_ingredient_name
CANAKINUMAB
unii
37CQ2C7X93
brand_name
Ilaris
brand_name_base
Ilaris
product_ndc
66447-0101
application_number
BLA125319
spl_id
1f1e499e-9cd3-fe2b-e063-6294a90a5e04
package_ndc
66447-0101-9
package_description
2 kg in 1 BOTTLE (66447-0101-9)
spl_set_id
7d271f3b-e4f9-4d80-8dcf-28d49123f80e
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class